vs
LIVEPERSON INC(LPSN)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
LIVEPERSON INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍($59.3M vs $35.5M),LIVEPERSON INC净利率更高(-77.8% vs -304.2%,领先226.5%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -19.0%),LIVEPERSON INC自由现金流更多($-12.0M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -16.6%)
LivePerson是一家全球性科技企业,专注于开发对话式商务与人工智能软件,相关产品与解决方案能够帮助企业搭建智能对话体系,优化客户沟通体验,助力企业实现数字化商务运营转型。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
LPSN vs RXRX — 直观对比
营收规模更大
LPSN
是对方的1.7倍
$35.5M
营收增速更快
RXRX
高出700.8%
-19.0%
净利率更高
LPSN
高出226.5%
-304.2%
自由现金流更多
LPSN
多$35.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-16.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $59.3M | $35.5M |
| 净利润 | $-46.1M | $-108.1M |
| 毛利率 | 73.2% | 59.8% |
| 营业利润率 | -68.7% | -304.8% |
| 净利率 | -77.8% | -304.2% |
| 营收同比 | -19.0% | 681.7% |
| 净利润同比 | 58.9% | 39.6% |
| 每股收益(稀释后) | $-9.22 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LPSN
RXRX
| Q4 25 | $59.3M | $35.5M | ||
| Q3 25 | $60.2M | $5.2M | ||
| Q2 25 | $59.6M | $19.2M | ||
| Q1 25 | $64.7M | $14.7M | ||
| Q4 24 | $73.2M | $4.5M | ||
| Q3 24 | $74.2M | $26.1M | ||
| Q2 24 | $79.9M | $14.4M | ||
| Q1 24 | $85.1M | $13.8M |
净利润
LPSN
RXRX
| Q4 25 | $-46.1M | $-108.1M | ||
| Q3 25 | $8.7M | $-162.3M | ||
| Q2 25 | $-15.7M | $-171.9M | ||
| Q1 25 | $-14.1M | $-202.5M | ||
| Q4 24 | $-112.1M | $-178.9M | ||
| Q3 24 | $-28.3M | $-95.8M | ||
| Q2 24 | $41.8M | $-97.5M | ||
| Q1 24 | $-35.6M | $-91.4M |
毛利率
LPSN
RXRX
| Q4 25 | 73.2% | 59.8% | ||
| Q3 25 | 71.4% | -183.8% | ||
| Q2 25 | 69.7% | -4.9% | ||
| Q1 25 | 71.8% | -48.0% | ||
| Q4 24 | 77.4% | -181.4% | ||
| Q3 24 | 73.1% | 53.7% | ||
| Q2 24 | 79.4% | 36.2% | ||
| Q1 24 | 71.3% | 19.1% |
营业利润率
LPSN
RXRX
| Q4 25 | -68.7% | -304.8% | ||
| Q3 25 | -24.2% | -3327.6% | ||
| Q2 25 | -10.8% | -916.8% | ||
| Q1 25 | -26.2% | -1297.9% | ||
| Q4 24 | -138.0% | -4042.4% | ||
| Q3 24 | -21.6% | -377.1% | ||
| Q2 24 | -37.3% | -697.4% | ||
| Q1 24 | -42.7% | -698.4% |
净利率
LPSN
RXRX
| Q4 25 | -77.8% | -304.2% | ||
| Q3 25 | 14.5% | -3135.3% | ||
| Q2 25 | -26.4% | -894.2% | ||
| Q1 25 | -21.8% | -1373.3% | ||
| Q4 24 | -153.2% | -3935.5% | ||
| Q3 24 | -38.1% | -367.5% | ||
| Q2 24 | 52.3% | -676.6% | ||
| Q1 24 | -41.8% | -662.4% |
每股收益(稀释后)
LPSN
RXRX
| Q4 25 | $-9.22 | $-0.17 | ||
| Q3 25 | $-2.76 | $-0.36 | ||
| Q2 25 | $-0.17 | $-0.41 | ||
| Q1 25 | $-0.24 | $-0.50 | ||
| Q4 24 | $-17.23 | $-0.56 | ||
| Q3 24 | $-4.74 | $-0.34 | ||
| Q2 24 | $-0.33 | $-0.40 | ||
| Q1 24 | $-0.40 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $95.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-44.5M | $1.1B |
| 总资产 | $454.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
LPSN
RXRX
| Q4 25 | $95.0M | $743.3M | ||
| Q3 25 | $106.7M | $659.8M | ||
| Q2 25 | $162.0M | $525.1M | ||
| Q1 25 | $176.3M | $500.5M | ||
| Q4 24 | $183.2M | $594.4M | ||
| Q3 24 | $142.1M | $427.6M | ||
| Q2 24 | $146.0M | $474.3M | ||
| Q1 24 | $127.1M | $296.3M |
总债务
LPSN
RXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | $512.1M | — |
股东权益
LPSN
RXRX
| Q4 25 | $-44.5M | $1.1B | ||
| Q3 25 | $-22.1M | $1.0B | ||
| Q2 25 | $-82.4M | $919.1M | ||
| Q1 25 | $-74.9M | $933.9M | ||
| Q4 24 | $-67.3M | $1.0B | ||
| Q3 24 | $45.9M | $524.6M | ||
| Q2 24 | $66.6M | $584.4M | ||
| Q1 24 | $19.2M | $401.2M |
总资产
LPSN
RXRX
| Q4 25 | $454.7M | $1.5B | ||
| Q3 25 | $511.4M | $1.4B | ||
| Q2 25 | $604.2M | $1.3B | ||
| Q1 25 | $596.2M | $1.3B | ||
| Q4 24 | $607.8M | $1.4B | ||
| Q3 24 | $692.0M | $726.5M | ||
| Q2 24 | $703.8M | $775.9M | ||
| Q1 24 | $724.7M | $557.8M |
负债/权益比
LPSN
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 26.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-9.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-12.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | -20.2% | -133.1% |
| 资本支出强度资本支出/营收 | 3.9% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-42.5M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
LPSN
RXRX
| Q4 25 | $-9.7M | $-46.1M | ||
| Q3 25 | $-6.0M | $-117.4M | ||
| Q2 25 | $-11.7M | $-76.4M | ||
| Q1 25 | $-3.1M | $-132.0M | ||
| Q4 24 | $-3.1M | $-115.4M | ||
| Q3 24 | $4.8M | $-59.2M | ||
| Q2 24 | $-17.9M | $-82.2M | ||
| Q1 24 | $1.1M | $-102.3M |
自由现金流
LPSN
RXRX
| Q4 25 | $-12.0M | $-47.3M | ||
| Q3 25 | $-8.9M | $-117.6M | ||
| Q2 25 | $-14.8M | $-79.6M | ||
| Q1 25 | $-6.9M | $-133.8M | ||
| Q4 24 | $-6.8M | $-116.7M | ||
| Q3 24 | $-230.0K | $-63.8M | ||
| Q2 24 | $-22.9M | $-83.4M | ||
| Q1 24 | $-10.4M | $-109.0M |
自由现金流率
LPSN
RXRX
| Q4 25 | -20.2% | -133.1% | ||
| Q3 25 | -14.8% | -2272.5% | ||
| Q2 25 | -24.9% | -413.9% | ||
| Q1 25 | -10.6% | -907.4% | ||
| Q4 24 | -9.2% | -2567.7% | ||
| Q3 24 | -0.3% | -244.6% | ||
| Q2 24 | -28.7% | -578.5% | ||
| Q1 24 | -12.2% | -789.9% |
资本支出强度
LPSN
RXRX
| Q4 25 | 3.9% | 3.5% | ||
| Q3 25 | 4.8% | 4.7% | ||
| Q2 25 | 5.3% | 16.4% | ||
| Q1 25 | 5.8% | 12.4% | ||
| Q4 24 | 5.0% | 28.6% | ||
| Q3 24 | 6.8% | 17.5% | ||
| Q2 24 | 6.2% | 8.2% | ||
| Q1 24 | 13.5% | 48.2% |
现金转化率
LPSN
RXRX
| Q4 25 | — | — | ||
| Q3 25 | -0.69× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
RXRX
暂无分部数据